<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6359210</article-id><article-id pub-id-type="doi">10.3390/ijms20020405</article-id><article-id pub-id-type="publisher-id">ijms-20-00405</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Peach Kernel Oil Downregulates Expression of Tissue Factor and Reduces Atherosclerosis in ApoE knockout Mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hao</surname><given-names>Erwei</given-names></name><xref ref-type="aff" rid="af1-ijms-20-00405">1</xref><xref ref-type="aff" rid="af2-ijms-20-00405">2</xref><xref ref-type="author-notes" rid="fn1-ijms-20-00405">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Pang</surname><given-names>Guofeng</given-names></name><xref ref-type="aff" rid="af1-ijms-20-00405">1</xref><xref ref-type="aff" rid="af2-ijms-20-00405">2</xref><xref ref-type="author-notes" rid="fn1-ijms-20-00405">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Zhengcai</given-names></name><xref ref-type="aff" rid="af1-ijms-20-00405">1</xref><xref ref-type="aff" rid="af2-ijms-20-00405">2</xref><xref ref-type="author-notes" rid="fn1-ijms-20-00405">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Lai</surname><given-names>Yu-Heng</given-names></name><xref ref-type="aff" rid="af3-ijms-20-00405">3</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Jung-Ren</given-names></name><xref ref-type="aff" rid="af4-ijms-20-00405">4</xref></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Jinling</given-names></name><xref ref-type="aff" rid="af1-ijms-20-00405">1</xref><xref ref-type="aff" rid="af2-ijms-20-00405">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Kai</given-names></name><xref ref-type="aff" rid="af1-ijms-20-00405">1</xref><xref ref-type="aff" rid="af2-ijms-20-00405">2</xref></contrib><contrib contrib-type="author"><name><surname>Hou</surname><given-names>Xiaotao</given-names></name><xref ref-type="aff" rid="af1-ijms-20-00405">1</xref><xref ref-type="aff" rid="af2-ijms-20-00405">2</xref><xref rid="c1-ijms-20-00405" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6398-8672</contrib-id><name><surname>Hsiao</surname><given-names>Chung-Der</given-names></name><xref ref-type="aff" rid="af5-ijms-20-00405">5</xref><xref rid="c1-ijms-20-00405" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Jiagang</given-names></name><xref ref-type="aff" rid="af1-ijms-20-00405">1</xref><xref ref-type="aff" rid="af2-ijms-20-00405">2</xref><xref rid="c1-ijms-20-00405" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-20-00405"><label>1</label>Guangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China; <email>ewhao@163.com</email> (E.H.); <email>pangguof@126.com</email> (G.P.); <email>duzhengcai8@163.com</email> (Z.D.); <email>13257716536@163.com</email> (J.X.); <email>zhoukai46@126.com</email> (K.Z.)</aff><aff id="af2-ijms-20-00405"><label>2</label>Guangxi Collaborative Innovation Center for Research on Functional Ingredients of Agricultural Residues, Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China</aff><aff id="af3-ijms-20-00405"><label>3</label>Department of Chemistry, Chinese Culture University, Taipei 11114, Taiwan; <email>lyh21@ulive.pccu.edu.tw</email></aff><aff id="af4-ijms-20-00405"><label>4</label>Department of Biological Science &#x00026; Technology College of Medicine, I-Shou University, Kaohsiung 82445, Taiwan; <email>jrchen@isu.edu.tw</email></aff><aff id="af5-ijms-20-00405"><label>5</label>Department of Bioscience Technology, Chung Yuan Christian University, Chung-Li 32023, Taiwan</aff><author-notes><corresp id="c1-ijms-20-00405"><label>*</label>Correspondence: <email>xthou@126.com</email> (X.H.); <email>cdhsiao@cycu.edu.tw</email> (C.-D.H.); <email>denggjg53@126.com</email> (J.D.); Tel.: +86-138-7885-8205 (X.H.); +886-3265-3545 (C.-D.H.); +86-138-7715-8896 (J.D.)</corresp><fn id="fn1-ijms-20-00405"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>18</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2019</year></pub-date><volume>20</volume><issue>2</issue><elocation-id>405</elocation-id><history><date date-type="received"><day>19</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>16</day><month>1</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Atherosclerosis is the pathological process in arteries due to the plaque formation that is responsible for several diseases like heart disease, stroke and peripheral arterial disease. In this study, we performed in vitro and in vivo assays to evaluate the potential anti-atherosclerosis activity of peach kernel oil. For the in vitro assay, we incubated human umbilical vein endothelial cells (HUVEC) with tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) to induce tissue factors (TF, an essential mediator of hemostasis and trigger of thrombosis) elevation. We found that TNF-&#x003b1;-induced TF elevation was suppressed by peach kernel oil in a dose-dependent manner at both mRNA and protein levels. Peach kernel oil can significantly improve HUVEC viability, protect the endothelial cells, which achieved the goal of prevention of thrombotic diseases. For the in vivo assay, we investigated the effect and mechanism of peach kernel oil on preventing atherosclerotic lesion formation in ApoE knockout mice. Results show that peach kernel oil could reduce total cholesterol, triglyceride, low-density lipoprotein cholesterol levels, elevate the high-density lipoprotein cholesterol level in serum, and reduce the area of the aortic atherosclerotic lesions in high-fat diet fed ApoE knockout mice. Moreover, peach kernel oil treatment can significantly down regulate the expression of TF protein to inhibit the formation of atherosclerotic plaque. In conclusion, peach kernel oil may be a potential health food to prevent atherosclerosis in cardiovascular diseases.</p></abstract><kwd-group><kwd>peach kernel oil</kwd><kwd>tissue factor</kwd><kwd>atherosclerosis</kwd><kwd>tumor necrosis factor-&#x003b1;</kwd><kwd>human umbilical vein endothelial cells</kwd></kwd-group></article-meta></front><body><sec id="sec1-ijms-20-00405"><title>1. Introduction</title><p>Atherosclerosis, an advanced chronic inflammatory disease, is the most relevant cause of cardiovascular disorders and cerebrovascular ischemic diseases [<xref rid="B1-ijms-20-00405" ref-type="bibr">1</xref>,<xref rid="B2-ijms-20-00405" ref-type="bibr">2</xref>]. It involves a series of inflammatory responses within arterial lumen that accumulate plaques, which have a lipid-rich core and fibrous cap. Vascular endothelial cells (VEC) is a layer of cells that forms a barrier between blood stream and vascular smooth muscle, maintaining vascular permeability, secreting vascular active substances, communicating vascular message, which is associated with hemostatic function, anticoagulant, and antithrombotic functions [<xref rid="B3-ijms-20-00405" ref-type="bibr">3</xref>]. In vascular homeostasis, the endothelium regulates the vascular dilation and contraction through inhibiting or promoting the migration and proliferation of a layer of muscle cells [<xref rid="B4-ijms-20-00405" ref-type="bibr">4</xref>]. Therefore, endothelial dysfunction may induce atherosclerosis development, and tumor necrosis factor &#x003b1; (TNF-&#x003b1;) serves as an inflammatory mediator that can induce endothelial cells to express tissue factor (TF), activating the coagulation reaction, reducing the anti-thrombotic function of endothelial cells, which is causatively involved in the formation and development of atherosclerosis [<xref rid="B5-ijms-20-00405" ref-type="bibr">5</xref>,<xref rid="B6-ijms-20-00405" ref-type="bibr">6</xref>].</p><p>Tissue factor (TF) is the onset of exogenous coagulation factor, playing an important role in the formation of atherosclerosis [<xref rid="B7-ijms-20-00405" ref-type="bibr">7</xref>,<xref rid="B8-ijms-20-00405" ref-type="bibr">8</xref>,<xref rid="B9-ijms-20-00405" ref-type="bibr">9</xref>,<xref rid="B10-ijms-20-00405" ref-type="bibr">10</xref>]. After the atheromatous plaque rupture, plaque and TF in VEC entered the bloodstream, starting the exogenous coagulation process, leading to atherosclerosis [<xref rid="B9-ijms-20-00405" ref-type="bibr">9</xref>]. Overexpression of TF in rat arterial neointima can model thrombosis and progression of advanced atherosclerosis [<xref rid="B11-ijms-20-00405" ref-type="bibr">11</xref>]. Due to the regulatory function of endothelial cells, the TF associated with vasoconstriction or vasodilation have been considered as the key for atherosclerosis development [<xref rid="B12-ijms-20-00405" ref-type="bibr">12</xref>,<xref rid="B13-ijms-20-00405" ref-type="bibr">13</xref>]. Numerous therapies focus on lipid-lowing property to reverse the atherosclerosis. It has been demonstrated that peach kernel showed therapeutic function on cardiovascular diseases [<xref rid="B14-ijms-20-00405" ref-type="bibr">14</xref>]. Peach kernel is one of the nine plant ingredients used in a cocktail for cardiovascular disease [<xref rid="B15-ijms-20-00405" ref-type="bibr">15</xref>]. In previous study done by Rahma and El-Aal, the major component of kernels of peach fruits contain 54.5% and 27.5% oil and protein, respectively, but ash and total carbohydrates were quite low [<xref rid="B15-ijms-20-00405" ref-type="bibr">15</xref>]. The fat-soluble components in peach kernel oil&#x02019;s accounted for about 50% of the dry weight of the peach kernel [<xref rid="B16-ijms-20-00405" ref-type="bibr">16</xref>], which may have clinical benefits in Chinese herbal remedies [<xref rid="B17-ijms-20-00405" ref-type="bibr">17</xref>]. In addition, the dietary administration of apricot kernel oil in rat can causes improvement in liver antioxidant status of rats in comparison to sunflower oil which is a commonly consumed vegetable oil [<xref rid="B18-ijms-20-00405" ref-type="bibr">18</xref>]. The administration of apricot kernel oil in rats can significantly ameliorate inflammatory response [<xref rid="B19-ijms-20-00405" ref-type="bibr">19</xref>]. This observation promotes us to test the potential anti-atherosclerosis function of peach kernel oil in this study.</p><p>Apolipoprotein E (ApoE) plays an important role to maintain the normal levels of cholesterol and triglyceride in the serum by transporting fat (lipids) in the bloodstream from one tissue to another [<xref rid="B20-ijms-20-00405" ref-type="bibr">20</xref>]. Mice deficient for ApoE function showed hypercholesterolemia, increased VLDL, decreased HDL, displayed spontaneous plaques formation aged at 3 months-old, and this plaques/lesions formation can be greatly accelerated after feeding with high-fat diet [<xref rid="B21-ijms-20-00405" ref-type="bibr">21</xref>]. After applying the peach kernel oil, HUVEC endothelial cells showed increase averting the negative effect of the TF expression induced by TNF-&#x003b1;. In addition, we investigated the effects of peach kernel oil&#x02019;s on ApoE knockout mice, and observed decreased blood lipid levels, reduced size of the atherosclerotic lesions, and downregulated expression of the TF within the artery atheromatous plaques, which lent support for the exploring further the potential clinical application of the peach kernel oil in treating cardiovascular diseases.</p></sec><sec id="sec2-ijms-20-00405"><title>2. Results</title><sec id="sec2dot1-ijms-20-00405"><title>2.1. The Fatty Acid Composition of Peach Kernel Oil</title><p>The experimental procedure and workflow to test the potential anti-atherosclerosis function of the peach kernel oil in vitro and in vivo was summarized in <xref ref-type="fig" rid="ijms-20-00405-f001">Figure 1</xref>A,B. Gas chromatography&#x02013;mass spectrometry (GC-MS) was used to analyze the fatty acid composition of the peach kernel oil. The map for the total ion chromatograms of methyl-esterized peach kernel oil was shown in <xref ref-type="fig" rid="ijms-20-00405-f001">Figure 1</xref>C. Unsaturated fatty acid content in peach kernel oil accounted for 86% of the total fatty acid content. The main unsaturated fatty acid was oleic acid (55.2%) and linoleic acid (30.8%); the saturated fatty acids mainly were palmitic acid (7.97%), stearic acid (2.37%), and &#x003b1;-linolenic acid (0.11%) (<xref ref-type="fig" rid="ijms-20-00405-f001">Figure 1</xref>C). The lipid composition of peach kernel oil tested in this study is similar to previous report showing oleic acid and linoleic acid are two major unsaturated fatty acid in peach kernel oil [<xref rid="B15-ijms-20-00405" ref-type="bibr">15</xref>].</p></sec><sec id="sec2dot2-ijms-20-00405"><title>2.2. Peach Kernel Oil Affects HUVEC Viability and Inhibits TNF-&#x003b1;-Induced TF mRNA Expression</title><p>The effect of peach kernel oil on cell viability of HUVEC was tested by MTT assay. We did not add any chemicals in the normal group. As a vehicle control, DMSO was added for evaluating the solvent effect. For the model group, TNF-&#x003b1; was added to the culture medium to stimulate TF protein expression. For the positive group, simvastatin was added to HUVEC to suppress the TF protein induction by TNF-&#x003b1; stimulation. We found that HUVEC viability significantly increased in the positive group (+simvastatin) and in peach kernel oil treated group (<xref ref-type="fig" rid="ijms-20-00405-f002">Figure 2</xref>A). In the peach kernel oil-treated groups, we found the HUVEC viability and the amount of exogenous peach kernel oil added display a positive dose-dependent relationship. It is intriguing to find the HUVEC viability can reach similar level to the positive group (+simvastatin) after receiving a very low dose peach kernel oil treatment (0.05 &#x003bc;g/L).</p><p>In the positive control group (+simvastatin) and peach kernel oil treated group (from 0.01 to 0.2 &#x003bc;g/mL), chemicals were added to HUVEC culture medium as a pretreatment. Then, TNF-&#x003b1; protein was added to the culture medium induce TF mRNA expression. As a vehicle group, DMSO was added to evaluate the solvent effect. The result showed that the expression of TF mRNA in the model group (+TNF-&#x003b1; protein) was significantly elevated. However, when either simvastatin (positive group) or different doses of peach kernel oil were applied, the TF mRNA expression levels were significantly decreased, suggesting that peach kernel oil inhibits TF mRNA induction in vitro (<xref ref-type="fig" rid="ijms-20-00405-f002">Figure 2</xref>B). We found that the TF mRNA expression can reach similar level with the positive group (+simvastatin) after receiving a very low dose peach kernel oil treatment (0.05 &#x003bc;g/L). This might be due to different mechanism between simvastatin and peach kernel oil on decreasing TF expression.</p></sec><sec id="sec2dot3-ijms-20-00405"><title>2.3. Peach Kernel Oil Decreases TNF-&#x003b1;-Induced TF Protein Expression in HUVEC</title><p>To provide quantitative data, we applied ELISA to validate TF protein expression in HUVEC. After pretreating HUVEC with simvastatin or peach kernel oil, TNF-&#x003b1; protein was added to HUVEC culture medium to induce TF protein expression. The results showed that the TNF-&#x003b1; could significantly promote TF protein expression as compared to the normal or vehicle group. Simvastatin and different doses of peach kernel oil significantly inhibited TF protein expression in HUVEC (<xref ref-type="fig" rid="ijms-20-00405-f002">Figure 2</xref>C). More peach kernel oil added, more significant lower level of TF protein was detected.</p><p>We also performed immnuohistochemistry (IHC) to compare TF protein expression in situ in HUVEC after receiving different treatments. As expected, the results showed that the TNF-&#x003b1; could significantly elevate TF protein expression in HUVEC in the model group (yellow, <xref ref-type="fig" rid="ijms-20-00405-f002">Figure 2</xref>F). The normal or solvent group, on the contrary, TF protein was barely detected (<xref ref-type="fig" rid="ijms-20-00405-f002">Figure 2</xref>D,E). After administration of simvastatin, the cellular level of TF protein expression was reduced (<xref ref-type="fig" rid="ijms-20-00405-f002">Figure 2</xref>L). The administration of peach kernel oil also significantly inhibited the TF protein expression in HUVEC in a dose-dependent manner (<xref ref-type="fig" rid="ijms-20-00405-f002">Figure 2</xref>G&#x02013;K).</p></sec><sec id="sec2dot4-ijms-20-00405"><title>2.4. Detection of TC, TG, HDL-C and LDL-C Levels</title><p>For the in vivo assay, we fed ApoE knockout (KO) mice with high-fat diet for four weeks and later the potential anti-atherosclerosis effect of peach kernel oil in ApoE KO mice was evaluated (<xref ref-type="fig" rid="ijms-20-00405-f003">Figure 3</xref>). Both normal and model groups of mice were supplement a high-fat feeding for 8 weeks to establish the model of atherosclerosis in wild type and ApoE KO mice. The high-fat diet containing 21% fat, 0.5% cholesterol and 78.5% other basic constitutions. After the high-fat feeding for 4 weeks, mice were subjected 5 mg&#x000b7;kg<sup>&#x02212;1</sup>&#x000b7;d<sup>&#x02212;1</sup> of simvastatin, high dose (2 g&#x000b7;kg<sup>&#x02212;1</sup>&#x000b7;d<sup>&#x02212;1</sup>), or low dose (5 g&#x000b7;kg<sup>&#x02212;1</sup>&#x000b7;d<sup>&#x02212;1</sup>) of peach kernel oil. The animals were sacrificed and total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) levels, and the high-density lipoprotein cholesterol (HDL-C) levels in the serum was compared. Compared to the normal group, TC, TG and LDL-C levels were elevated; while the HDL-C level was significant reduced in the model group (ApoE KO mice receiving saline). For positive group (ApoE KO mice receiving simvastatin), we found administration of simvastatin significantly restored the phenotype detected in the model group, showing reduced TC, TG and LDL-C levels and elevated HDL-C level. It is intriguing to find that the administration of peach kernel oil even at dose as low as 2 g&#x000b7;kg<sup>&#x02212;1</sup>&#x000b7;d<sup>&#x02212;1</sup> could generate a similar rescue effect with simvastatin positive group (<xref ref-type="fig" rid="ijms-20-00405-f003">Figure 3</xref>).</p></sec><sec id="sec2dot5-ijms-20-00405"><title>2.5. Peach Kernel Oil Reduced Aortic Atherosclerosis in ApoE KO Mice</title><p>In the normal group (wild type C57BL/6 strain mice receiving saline), it was seldom to detect aortic atherosclerosis formation after 8 weeks of normal diet (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>A) or high-fat diet feeding (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>B). In the model group (ApoE KO mice fed with high-fat diet for 8 weeks), atherosclerosis lesions, lumen blocking, disorder of smooth muscle, formation and accumulation of many foam cells, large number of inflammatory cells, and atherosclerosis plate-cholesterol clefts were detected (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>C). Simvastatin is currently considered as an effective treatment for decreasing serum lipid level [<xref rid="B22-ijms-20-00405" ref-type="bibr">22</xref>,<xref rid="B23-ijms-20-00405" ref-type="bibr">23</xref>]. ApoE KO mice treated with simvastatin were used as a positive group for evaluating potential anti-atherosclerosis lesions function of the peach kernel oil (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>D). Mice treated with either high or low dose of peach kernel oil, the degree of aortic atherosclerosis and inflammation were found to be significantly attenuated (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>E,F). The index of aortic atherosclerotic lesions was listed in <xref rid="ijms-20-00405-t001" ref-type="table">Table 1</xref>. Compared with the normal group, aortic atherosclerotic lesions area of mice in the positive group, high and low dose peach kernel oil groups decreased significantly (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>G), the aortic atherosclerotic lesions area and the aortic atherosclerotic lesions area/cross-sectional area (CSA) of the vascular wall also reduced significantly (<xref rid="ijms-20-00405-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec2dot6-ijms-20-00405"><title>2.6. Peach Kernel Oil Reduced the TF Protein Expression in Atherosclerotic Plaques</title><p>Tissue factor (TF) is the onset of exogenous coagulation factor, playing an important role in the formation of atherosclerosis [<xref rid="B7-ijms-20-00405" ref-type="bibr">7</xref>]. Therefore, we measured the TF protein expression within the atherosclerotic plaques in mice by immunohistochemical method to evaluate the potential anti-atherosclerosis effect of peach kernel oil. TF protein expression in aorta vascular tissue of normal mice was at low level and only can be detected in the outer membrane (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>H). Compared with the normal group, the aortic TF expression increased noticeably in model group, while TF widely expressed in the plaque intima fiberous connective tissue (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>I). Compared with model group, the expression of TF protein in positive (+simvastatin) (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>J), high (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>K) and low (<xref ref-type="fig" rid="ijms-20-00405-f004">Figure 4</xref>L) doses of peach kernel oil groups were slightly reduced.</p></sec><sec id="sec2dot7-ijms-20-00405"><title>2.7. Peach Kernel Oil Reduced the Inflammatory Response In Vitro</title><p>To explore the potential mechanism for peach kernel oil on anti-atherosclerosis, we performed in vitro assay to test the potential anti-inflammatory function of peach kernel oil on suppressing nitric oxide (NO) release from RAW264.7 macrophage cell lines after challenged with lipopolysaccharide (LPS). For model group, we found the LPS administration can significantly stimulate the inflammation response on elevating NO releasing level. However, this LPS-induced inflammation can be attenuated when dexamethasone (an anti-inflammation drug) was administrated. By co-incubated with peach kernel oil at high dose and LPS, we found the NO level can be significantly reduced to a level similar normal group when peach kernel oil was given at 200 &#x003bc;g/mL, and to a level close to positive control of dexamethasone when peach kernel oil was given at either 100 or 50 &#x003bc;g/mL (<xref ref-type="fig" rid="ijms-20-00405-f0A1">Figure A1</xref>). Those results clearly demonstrated peach kernel oil display anti-inflammation effect when tested in vitro on RAW264.7 macrophage cell lines.</p></sec></sec><sec id="sec3-ijms-20-00405"><title>3. Discussion</title><p>Atherosclerosis is one of the important risk factors to induce cardiovascular diseases, such as coronary heart disease, cerebral infarction, and myocardial infarction, which has become a serious threat to human health [<xref rid="B1-ijms-20-00405" ref-type="bibr">1</xref>,<xref rid="B24-ijms-20-00405" ref-type="bibr">24</xref>]. ApoE KO mice is one of the common animal models that has been used for atherosclerosis research in vivo [<xref rid="B6-ijms-20-00405" ref-type="bibr">6</xref>,<xref rid="B25-ijms-20-00405" ref-type="bibr">25</xref>]. The mice that were lack of the ApoE activity spontaneously led to atherosclerosis due to high total cholesterol levels [<xref rid="B26-ijms-20-00405" ref-type="bibr">26</xref>]. In our study, we observed that the ApoE KO mice fed with high-fat diet for 8 weeks, showed a serious hyperlipidemia at 16 weeks of age. The aortic root formed atherosclerosis, which confirmed atherosclerosis model was successfully established. Compared with the model group (treated with simvastatin), the aortic atherosclerotic area in different doses of peach kernel oil groups were reduced, which illustrated that peach kernel oil indeed can inhibit the development of atherosclerosis.</p><p>Alterations of endothelial cells and the vasculature play important roles in the pathogenesis of human diseases. Endothelial cells have the key function on maintaining functional capillaries [<xref rid="B27-ijms-20-00405" ref-type="bibr">27</xref>,<xref rid="B28-ijms-20-00405" ref-type="bibr">28</xref>]. The endothelium is directly involved in peripheral vascular disease, stroke and heart disease. Endothelial cells form the luminal vascular surface and thus play crucial role on regulating coagulation. Endothelial cells control the clotting system by regulating the expression of binding sites for anticoagulant and procoagulant factors on the cell surface. In the quiescent state, endothelial cells maintain blood fluidity by promoting the activity of numerous anticoagulant pathways, including the protein C pathway. After activation, the balance of endothelial properties can favor the clot formation through the coordinated induction of procoagulant and suppression of anticoagulant mechanisms. Tumor necrosis factor suppresses the formation of throbomodulin, an endothelial anticoagulant cofactor, and induces the expression of tissue factor (TF), which is a procoagulant cofactor [<xref rid="B29-ijms-20-00405" ref-type="bibr">29</xref>]. Under the condition of damaged endothelial cells, a high level of TF was released and promoted thrombosis. TF is the transmembrane singly linked glycoprotein and composed by 263 amino acid residues [<xref rid="B30-ijms-20-00405" ref-type="bibr">30</xref>]. Blood cells and endothelial cells were directly contacted with the circulation, which do not express tissue factor in general condition. Many stimulating factors, such as bacterial endotoxin, tumor necrosis factor, and type oxidized low density lipoprotein (ox-LDL) attack vascular endothelial cells and monocytes to express TF [<xref rid="B31-ijms-20-00405" ref-type="bibr">31</xref>,<xref rid="B32-ijms-20-00405" ref-type="bibr">32</xref>]. Excessive expression of TF was closely related to the thrombosis of many diseases, such as sepsis, cancer and atherosclerosis [<xref rid="B33-ijms-20-00405" ref-type="bibr">33</xref>]. TNF-&#x003b1; is a kind of inflammatory cytokines that affects the anti-coagulant property of vascular endothelial cells. It was secreted by mononuclear macrophages and effected on vascular endothelial cells by the damage [<xref rid="B6-ijms-20-00405" ref-type="bibr">6</xref>]. It also induced proliferation of mononuclear cells, endothelial adhesion, and inward transfer subcutaneous clearance, to form the smooth muscle cells associated with sex foam cells and macrophage foam cells, which showed impacts on the stability of atherosclerotic plaque [<xref rid="B34-ijms-20-00405" ref-type="bibr">34</xref>]. Previous studies demonstrated that TNF-&#x003b1; damaged human umbilical vein endothelial cells (HUVEC) and released inflammatory factor TF [<xref rid="B35-ijms-20-00405" ref-type="bibr">35</xref>].</p><p>Peach kernel promotes blood circulation and removes blood stasis [<xref rid="B36-ijms-20-00405" ref-type="bibr">36</xref>]. It has the significant clinical efficacy that significantly improved the blood rheology and microcirculation in the animal model of stasis heat exchange and haemorrheological nature blood stasis. Peach kernel oil also can improve microcirculation of normal mice and hemorheology index in rats [<xref rid="B37-ijms-20-00405" ref-type="bibr">37</xref>]. Peach kernel oil is thought to be the main active constituents of peach kernel to promote blood circulation and to remove blood plaques. In this study, the effect of peach kernel oil on atherosclerosis were demonstrated, both by in vivo and in vitro experiments. Results showed that peach kernel oil not only reversed the abnormal blood lipid levels, but also reduced the degree and area of the aortic atherosclerotic lesions in the ApoE KO mice. It also reduced the levels of TF protein expression in artery atheromatous plaques, which suggested an effect of deceleration of the atherosclerosis process (summarized in <xref ref-type="fig" rid="ijms-20-00405-f005">Figure 5</xref>). Peach kernel oil may affect the activation of blood coagulation system and maintain the dynamic balance in endogenous vascular active substances, thereby improve the thrombotic diseases such as atherosclerosis. By collection of in vitro evidence in this study and in vivo evidence in previous study [<xref rid="B18-ijms-20-00405" ref-type="bibr">18</xref>], we proposed the anti-atherosclerosis function of peach kernel oil might related to its anti-inflammatory (<xref ref-type="fig" rid="ijms-20-00405-f0A1">Figure A1</xref>) and anti-oxidative capacity. In conclusion, by combining much in vitro and in vivo evidence, we provided strong evidence showing peach kernel oil showed great activity on down-regulating the expression of TF protein to inhibit the formation of atherosclerotic plaque, which may have potential to develop into health food to prevent atherosclerosis in cardiovascular diseases in the future.</p></sec><sec id="sec4-ijms-20-00405"><title>4. Materials and Methods</title><sec id="sec4dot1-ijms-20-00405"><title>4.1. Extraction of Peach Kernel Oil</title><p>Peach kernel (batch number 13110814) was originally collected from Hebei, China and purchased from People Big Pharmacy Corporation in Guangxi, China. Twenty grams of peach kernel was extracted by 130 mL petroleum ether extraction solvent at 65 &#x000b0;C for 2.5 h. The extract was refluxed in water bath pot, and filtered. The organic solvent was removed in water bath at 37 &#x000b0;C. Oil rate was weighed and calculated. Extraction rate was calculated as: actual amount of oil extraction (g)/quality of raw material (g) &#x000d7; 100%.</p></sec><sec id="sec4dot2-ijms-20-00405"><title>4.2. Analysis of Fatty Acid Composition</title><p>After peach kernel oil undergoing methyl-ester process, the fatty acid composition of peach kernel oil was analyzed by GC-MS chromatograph (Agilent 6890N, Santa Clara, CA, USA). GC-MS conditions: 30 m &#x000d7; 0.25 mm &#x000d7; 0.25 &#x003bc;m capillary column with a flow rate of carrier gas at 0.7 mL/min. The split ratio was 50:1, and vaporizing chamber temperature was 240 &#x000b0;C. The column temperature was at 180 &#x000b0;C with 1 &#x003bc;L sample quantity. Needing EI ion source temperature was at 230 &#x000b0;C. The electron energy was at 70 ev. The electronic energy multiplier voltage was at 0.9 kV, with 40&#x02013;600 amu scanning range.</p></sec><sec id="sec4dot3-ijms-20-00405"><title>4.3. Cell Culture, Drug Treatment and Grouping</title><p>HUVEC, purchased from Shanghai medical college, were grown in DMEM (containing 10% fetal bovine serum, 100 u/mL penicillin and streptomycin) at 37 &#x000b0;C with 5% CO<sub>2</sub>. Peach kernel oil was dissolved by protein adsorption method, which dissolved peach kernel oil in anhydrous ethanol to reached the concentration of 20 &#x003bc;g/mL. Peach kernel oil was preheated at 55 &#x000b0;C and added into DMEM with 1% bovine serum albumin (BSA). Mixture was dissolved by the oscillation at 55 &#x000b0;C water bath before experiment. HUVEC at the density of 5 &#x000d7; 10<sup>6</sup>/mL were inoculated onto 6-well petri dish. Normal group: cells in serum-free 20 &#x003bc;L DMEM medium without drugs. Normal vehicle group: cells in 20 &#x003bc;L 1% anhydrous ethanol, 1% BSA, serum-free 1% DMEM medium without drugs. Model group: cells in TNF-&#x003b1; (final concentration at 20 ng/mL). Positive group: simvastatin (final concentration of 5 &#x003bc;mol/L) was added after 18 h incubation, 20 &#x003bc;L TNF-&#x003b1; (final concentration for 10 ng/mL). Each dose Peach kernel oil groups: different concentrations of peach kernel oil (0.01, 0.05, 0.1, 0.15, 0.2 &#x003bc;g/mL) were added after the incubation time for 18 h, then TNF-&#x003b1; (final concentration at 10 ng/mL) was added and incubated for 6 h.</p></sec><sec id="sec4dot4-ijms-20-00405"><title>4.4. MTT Assay</title><p>Cells were incubated in 10 &#x003bc;L MTT reagent (5 mg/mL) for 4 h at 37 &#x000b0;C and 5% CO<sub>2</sub>. Removed the MTT reagent and washed before adding 100 &#x003bc;L DMSO to each well for 10 min to dissolve formed crystal. Spectrophotometer was used to determine absorbance at 570 nm. The average absorbance and the cell vitality were calculated as follow: cell viability = (OD value of dosing group/OD value of normal group) &#x000d7; 100%. The OD value of dosing group and normal group through the blank group.</p></sec><sec id="sec4dot5-ijms-20-00405"><title>4.5. Anti-Inflammatory Effect of Peach Kernel Oil</title><p>RAW264.7 macrophage cell lines were incubated in Dulbecco&#x02019;s Modified Eagle Medium (DMEM) medium with 1% BSA at 37 &#x000b0;C and 5% CO<sub>2</sub>. For normal group, there are no chemicals were added. For model group, lipopolysaccharide (LPS) at 1 &#x003bc;g/mL concentration was used to induce inflammation and nitric oxide (NO) release. For positive group, dexamethasone at 1 &#x003bc;g/mL concentration was co-incubated with LPS at 1 &#x003bc;g/mL concentration to attenuate inflammation and nitric oxide (NO) release. For Peach kernel oil (PKO) groups, PKO at different concentration of 200, 100 and 50 &#x003bc;g/mL were co-incubated with LPS at 1 &#x003bc;g/mL concentration to test its potential function on anti-inflammation and suppress NO release.</p></sec><sec id="sec4dot6-ijms-20-00405"><title>4.6. Quantitative Realtime-PCR (qRT-PCR)</title><p>Reverse transcription was performed to synthesis cDNA by using commercial kit (Dalian Treasure Biological Engineering). PCR primers was purchased from Beijing liuhe genomics technology as followed: TF forward 5&#x02032;-CTGAGCCCTTCCTTCTCAGC-3&#x02032;, the reverse 5&#x02032;-GATCACGCAGACCCTTTTAGA-3&#x02032;; ACTB forward 5&#x02032;-CAGGCACCAGGGCGTGAT-3&#x02032;, the reversed 5&#x02032;-TAGCAACGTACATGGCTGGG-3&#x02032;. The relative expression of TF mRNA was calculated by the 2<sup>&#x02212;&#x02206;&#x02206;<italic>C</italic>t</sup> method [<xref rid="B38-ijms-20-00405" ref-type="bibr">38</xref>].</p></sec><sec id="sec4dot7-ijms-20-00405"><title>4.7. Preparation of the Mouse Model of Atherosclerosis</title><p>ApoE knockout and normal mice (C57BL/6 strain) at 8 weeks of age were purchased from Health Science Center in Peking University. Thirty-two male ApoE knockout mice (C57BL/6 strain) aged at 8 weeks old were randomly divided into four model groups: model, positive, high dose and low dose peach kernel oil group, while 8 wild type male mice as the normal group. Mouse were given a high-fat feeding for 8 weeks to establish the model of atherosclerosis in wild type and ApoE knockout mice. The high-fat diet containing 21% fat, 0.5% cholesterol and 78.5% other basic constitutions. After the high-fat feeding for 4 weeks, mice were fed with 5 mg&#x000b7;kg<sup>&#x02212;1</sup>&#x000b7;d<sup>&#x02212;1</sup> of simvastatin, high dose (2 g&#x000b7;kg<sup>&#x02212;1</sup>&#x000b7;d<sup>&#x02212;1</sup>), or low dose (5 g&#x000b7;kg<sup>&#x02212;1</sup>&#x000b7;d<sup>&#x02212;1</sup>) of peach kernel oil. All experimental protocols and procedures involving mice were approved by the Committee for Animal Experimentation of Guangxi University of Chinese Medicine (ethical permission code SCXK-2014-0002 and permission date 24 December 2013). All experiments were performed in accordance with the guidelines for laboratory animals.</p></sec><sec id="sec4dot8-ijms-20-00405"><title>4.8. Sacrifice and Processing of the Specimens of Mice</title><p>Mice were under fasting for more than 12 h before death. 0.2&#x02013;0.3 mL of 20% urethane saline solution injection was used to anesthesia mice. Saline and 4% paraformaldehyde in PBS were used to perfuse and fix aortic for 15 min. Completely separation the heart and the aorta by breaking out the heart and bifurcation form the aortic root to iliac artery. After taking 1.0 cm the aorta in aortic root of all mice, 4% paraformaldehyde was used to fixation, then performed the paraffin sectioning.</p></sec><sec id="sec4dot9-ijms-20-00405"><title>4.9. Blood Lipid Index</title><p>The total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) level in serum were determined by the commercial kits (Chang Chun HuiLi Biotech Co., LTD).</p></sec><sec id="sec4dot10-ijms-20-00405"><title>4.10. Histology</title><p>Specimen from aorta was fixed in 4% paraformaldehyde and conventionally embedded in paraffin. Sample was cut into 5 &#x003bc;m in each section and H&#x00026;E staining was applied. Image analysis was done by Image Pro Plus 6.0 software (<uri xlink:href="http://www.mediacy.com/imageproplus">http://www.mediacy.com/imageproplus</uri>). The size of mouse artery atheromatous plaque was measured by the scale on blood count plate. The diameter of blood vessel wall was calculated from outside boundary of artery elastic layer to the elastic layer according to previous published method [<xref rid="B39-ijms-20-00405" ref-type="bibr">39</xref>]. Paraffin slides were de-wax and then performed immunohistochemical staining with rabbit anti-TF monoclonal antibodies (Abcam) at 1:100 dilution. After immunohistochemical staining, TF protein staining in the arterial wall and plaques, was developed by DAB Peroxidase Substrate Kit.</p></sec><sec id="sec4dot11-ijms-20-00405"><title>4.11. Detection of TF Protein Content by ELISA</title><p>The endothelial cells were washed with PBS three times before adding 15 nM octyl-B-<sc>d</sc>-glucopyranoside to lyse cells at 37 &#x000b0;C for 15 min. Cell extract was collected and incubated with 50 &#x003bc;L standard solution in each well at room temperature for 2 h. The TF protein content was later quantified by TF ELISA kit (ET1002-1, AssayPro) according to the manufacture&#x02019;s instruction at wavelength of 450 nm.</p></sec><sec id="sec4dot12-ijms-20-00405"><title>4.12. Statistical Analysis</title><p>Graphpad prism software (<uri xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</uri>) was used for statistical processing and the results were expressed as Average &#x000b1; standard error of mean (<inline-formula><mml:math id="mm2"><mml:mrow><mml:mover accent="true"><mml:mi>X</mml:mi><mml:mo>&#x000af;</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> &#x000b1; SEM). Data were analyzed by Student&#x02019;s two-tailed-<italic>t</italic>-test for comparison between two groups or one-way ANOVA for multiple group comparison. <italic>p</italic> value of less than 0.05 was considered statistically significant.</p></sec></sec></body><back><notes><title>Author Contributions</title><p>Conceptualization, Y.-H.L. and J.-R.C.; Data curation, E.H., G.P., Z.D., Y.-H.L., J.-R.C., K.Z. and C.-D.H.; Formal analysis, E.H., G.P., Z.D., Y.-H.L., J.X., K.Z. and C.-D.H.; Funding acquisition, J.D.; Investigation, X.H.; Methodology, C.-D.H.; Project administration, J.D.; Supervision, X.H., C.-D.H. and J.D.; Validation, C.-D.H.; Writing&#x02014;original draft, E.H., C.-D.H. and J.D.</p></notes><notes><title>Funding</title><p>This work was supported by Guangxi Natural Science Foundation (2013GXNSFBA019145) and Guangxi Science and Technology Plan Project (AD17129010, 17-259-20, AD17195025) to J.D.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><app-group><app id="app1-ijms-20-00405"><title>Appendix A</title><fig id="ijms-20-00405-f0A1" orientation="portrait" position="anchor"><label>Figure A1</label><caption><p>The potential anti-inflammatory function of peach kernel oil on suppressing nitric oxide (NO) release from RAW264.7 macrophage cell lines after challenged with lipopolysaccharide (LPS). Different labels above columns indicate a significant difference tested by One-way ANOVA and Tukey-HSD test with <italic>p</italic> &#x0003c; 0.01. For normal group, there are no chemicals were added. For model group, lipopolysaccharide (LPS) at 1 &#x003bc;g/mL concentration was used to induce inflammation and nitric oxide (NO) release. For positive group, dexamethasone at 1 &#x003bc;g/mL concentration was co-incubated with LPS at 1 &#x003bc;g/mL concentration to attenuate inflammation and nitric oxide (NO) release. For Peach kernel oil (PKO) groups, PKO at different concentration of 200, 100 and 50 &#x003bc;g/mL were co-incubated with LPS at 1 &#x003bc;g/mL concentration to test its potential function on anti-inflammation and suppress NO release.</p></caption><graphic xlink:href="ijms-20-00405-g0A1"/></fig></app></app-group><ref-list><title>References</title><ref id="B1-ijms-20-00405"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lusis</surname><given-names>A.J.</given-names></name></person-group><article-title>Atherosclerosis</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>233</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1038/35025203</pub-id><?supplied-pmid 11001066?><pub-id pub-id-type="pmid">11001066</pub-id></element-citation></ref><ref id="B2-ijms-20-00405"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>French Study of Aortic Plaques in Stroke Group</collab></person-group><article-title>Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke</article-title><source>N. Engl. J. Med.</source><year>1996</year><volume>334</volume><fpage>1216</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1056/NEJM199605093341902</pub-id><?supplied-pmid 8606716?><pub-id pub-id-type="pmid">8606716</pub-id></element-citation></ref><ref id="B3-ijms-20-00405"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cines</surname><given-names>D.B.</given-names></name><name><surname>Pollak</surname><given-names>E.S.</given-names></name><name><surname>Buck</surname><given-names>C.A.</given-names></name><name><surname>Loscalzo</surname><given-names>J.</given-names></name><name><surname>Zimmerman</surname><given-names>G.A.</given-names></name><name><surname>McEver</surname><given-names>R.P.</given-names></name><name><surname>Pober</surname><given-names>J.S.</given-names></name><name><surname>Wick</surname><given-names>T.M.</given-names></name><name><surname>Konkle</surname><given-names>B.A.</given-names></name><name><surname>Schwartz</surname><given-names>B.S.</given-names></name><etal/></person-group><article-title>Endothelial cells in physiology and in the pathophysiology of vascular disorders</article-title><source>Blood</source><year>1998</year><volume>91</volume><fpage>3527</fpage><lpage>3561</lpage><?supplied-pmid 9572988?><pub-id pub-id-type="pmid">9572988</pub-id></element-citation></ref><ref id="B4-ijms-20-00405"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davignon</surname><given-names>J.</given-names></name><name><surname>Ganz</surname><given-names>P.</given-names></name></person-group><article-title>Role of endothelial dysfunction in atherosclerosis</article-title><source>Circulation</source><year>2004</year><volume>109</volume><fpage>III27-32</fpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000131515.03336.f8</pub-id><?supplied-pmid 15198963?><pub-id pub-id-type="pmid">15198963</pub-id></element-citation></ref><ref id="B5-ijms-20-00405"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Turco</surname><given-names>S.</given-names></name><name><surname>Basta</surname><given-names>G.</given-names></name><name><surname>Lazzerini</surname><given-names>G.</given-names></name><name><surname>Chancharme</surname><given-names>L.</given-names></name><name><surname>Lerond</surname><given-names>L.</given-names></name><name><surname>De Caterina</surname><given-names>R.</given-names></name></person-group><article-title>Involvement of the tp receptor in TNF-&#x003b1;-induced endothelial tissue factor expression</article-title><source>Vasc. Pharmacol.</source><year>2014</year><volume>62</volume><fpage>49</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2014.03.007</pub-id><?supplied-pmid 24699252?><pub-id pub-id-type="pmid">24699252</pub-id></element-citation></ref><ref id="B6-ijms-20-00405"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>K.</given-names></name><name><surname>Zhai</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name></person-group><article-title>Attenuation of TNF-&#x003b1;-induced inflammatory injury in endothelial cells by ginsenoside rb1 via inhibiting NF-&#x003ba;B, JNK and p38 signaling pathways</article-title><source>Front. Pharmacol.</source><year>2017</year><volume>8</volume><fpage>464</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00464</pub-id><?supplied-pmid 28824425?><pub-id pub-id-type="pmid">28824425</pub-id></element-citation></ref><ref id="B7-ijms-20-00405"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubman</surname><given-names>M.B.</given-names></name><name><surname>Fallon</surname><given-names>J.T.</given-names></name><name><surname>Schecter</surname><given-names>A.D.</given-names></name><name><surname>Giesen</surname><given-names>P.</given-names></name><name><surname>Mendlowitz</surname><given-names>M.</given-names></name><name><surname>Fyfe</surname><given-names>B.S.</given-names></name><name><surname>Marmur</surname><given-names>J.D.</given-names></name><name><surname>Nemerson</surname><given-names>Y.</given-names></name></person-group><article-title>Tissue factor in the pathogenesis of atherosclerosis</article-title><source>Thromb. Haemost.</source><year>1997</year><volume>78</volume><fpage>200</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1055/s-0038-1657526</pub-id><pub-id pub-id-type="pmid">9198153</pub-id></element-citation></ref><ref id="B8-ijms-20-00405"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grover</surname><given-names>S.P.</given-names></name><name><surname>Mackman</surname><given-names>N.</given-names></name></person-group><article-title>Tissue factor: An essential mediator of hemostasis and trigger of thrombosis</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2018</year><volume>38</volume><fpage>709</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.117.309846</pub-id><pub-id pub-id-type="pmid">29437578</pub-id></element-citation></ref><ref id="B9-ijms-20-00405"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremoli</surname><given-names>E.</given-names></name><name><surname>Camera</surname><given-names>M.</given-names></name><name><surname>Toschi</surname><given-names>V.</given-names></name><name><surname>Colli</surname><given-names>S.</given-names></name></person-group><article-title>Tissue factor in atherosclerosis</article-title><source>Atherosclerosis</source><year>1999</year><volume>144</volume><fpage>273</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/S0021-9150(99)00063-5</pub-id><pub-id pub-id-type="pmid">10407489</pub-id></element-citation></ref><ref id="B10-ijms-20-00405"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toschi</surname><given-names>V.</given-names></name><name><surname>Gallo</surname><given-names>R.</given-names></name><name><surname>Lettino</surname><given-names>M.</given-names></name><name><surname>Fallon</surname><given-names>J.T.</given-names></name><name><surname>Gertz</surname><given-names>S.D.</given-names></name><name><surname>Fern&#x000e1;ndez-Ortiz</surname><given-names>A.</given-names></name><name><surname>Chesebro</surname><given-names>J.H.</given-names></name><name><surname>Badimon</surname><given-names>L.</given-names></name><name><surname>Nemerson</surname><given-names>Y.</given-names></name><name><surname>Fuster</surname><given-names>V.</given-names></name></person-group><article-title>Tissue factor modulates the thrombogenicity of human atherosclerotic plaques</article-title><source>Circulation</source><year>1997</year><volume>95</volume><fpage>594</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.95.3.594</pub-id><pub-id pub-id-type="pmid">9024145</pub-id></element-citation></ref><ref id="B11-ijms-20-00405"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasenstab</surname><given-names>D.</given-names></name><name><surname>Lea</surname><given-names>H.</given-names></name><name><surname>Hart</surname><given-names>C.E.</given-names></name><name><surname>Lok</surname><given-names>S.</given-names></name><name><surname>Clowes</surname><given-names>A.W.</given-names></name></person-group><article-title>Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis</article-title><source>Circulation</source><year>2000</year><volume>101</volume><fpage>2651</fpage><lpage>2657</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.101.22.2651</pub-id><?supplied-pmid 10840019?><pub-id pub-id-type="pmid">10840019</pub-id></element-citation></ref><ref id="B12-ijms-20-00405"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luscher</surname><given-names>T.F.</given-names></name><name><surname>Barton</surname><given-names>M.</given-names></name></person-group><article-title>Biology of the endothelium</article-title><source>Clin. Cardiol.</source><year>1997</year><volume>20</volume><fpage>II-3-10</fpage><?supplied-pmid 9422846?><pub-id pub-id-type="pmid">9422846</pub-id></element-citation></ref><ref id="B13-ijms-20-00405"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludmer</surname><given-names>P.L.</given-names></name><name><surname>Selwyn</surname><given-names>A.P.</given-names></name><name><surname>Shook</surname><given-names>T.L.</given-names></name><name><surname>Wayne</surname><given-names>R.R.</given-names></name><name><surname>Mudge</surname><given-names>G.H.</given-names></name><name><surname>Alexander</surname><given-names>R.W.</given-names></name><name><surname>Ganz</surname><given-names>P.</given-names></name></person-group><article-title>Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries</article-title><source>N. Engl. J. Med.</source><year>1986</year><volume>315</volume><fpage>1046</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1056/NEJM198610233151702</pub-id><?supplied-pmid 3093861?><pub-id pub-id-type="pmid">3093861</pub-id></element-citation></ref><ref id="B14-ijms-20-00405"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Xue</surname><given-names>S.</given-names></name><name><surname>Kakuda</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Subramanian</surname><given-names>J.</given-names></name></person-group><article-title>Essential oil extracted from peach (prunus persica) kernel and its physicochemical and antioxidant properties</article-title><source>LWT Food Sci. Technol.</source><year>2011</year><volume>44</volume><fpage>2032</fpage><lpage>2039</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2011.05.012</pub-id></element-citation></ref><ref id="B15-ijms-20-00405"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahma</surname><given-names>E.</given-names></name><name><surname>El-Aal</surname><given-names>M.A.</given-names></name></person-group><article-title>Chemical characterization of peach kernel oil and protein: Functional properties, in vitro digestibility and amino acids profile of the flour</article-title><source>Food Chem.</source><year>1988</year><volume>28</volume><fpage>31</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/0308-8146(88)90004-0</pub-id></element-citation></ref><ref id="B16-ijms-20-00405"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litvinova</surname><given-names>L.B.</given-names></name></person-group><article-title>The effect of peach kernel oil on the sexual maturation of female rats</article-title><source>Eksp. Klin. Farmakol.</source><year>1998</year><volume>61</volume><fpage>43</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">9690077</pub-id></element-citation></ref><ref id="B17-ijms-20-00405"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname><given-names>Y.T.</given-names></name><name><surname>Ang</surname><given-names>X.L.</given-names></name><name><surname>Zhong</surname><given-names>X.M.</given-names></name><name><surname>Khoo</surname><given-names>K.S.</given-names></name></person-group><article-title>Interaction between warfarin and Chinese herbal medicines</article-title><source>Singap. Med. J.</source><year>2015</year><volume>56</volume><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.11622/smedj.2015004</pub-id></element-citation></ref><ref id="B18-ijms-20-00405"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutlu</surname><given-names>T.</given-names></name><name><surname>Durmaz</surname><given-names>G.</given-names></name><name><surname>Ates</surname><given-names>B.</given-names></name><name><surname>Erdogan</surname><given-names>A.</given-names></name></person-group><article-title>Protective effect of dietary apricot kernel oil supplementation on cholesterol levels and antioxidant status of liver in hypercholesteremic rats</article-title><source>J. Food Agric. Environ.</source><year>2009</year><volume>7</volume><fpage>61</fpage><lpage>65</lpage></element-citation></ref><ref id="B19-ijms-20-00405"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minaiyan</surname><given-names>M.</given-names></name><name><surname>Ghannadi</surname><given-names>A.</given-names></name><name><surname>Asadi</surname><given-names>M.</given-names></name><name><surname>Etemad</surname><given-names>M.</given-names></name><name><surname>Mahzouni</surname><given-names>P.</given-names></name></person-group><article-title>Anti-inflammatory effect of <italic>Prunus armeniaca</italic> L.(apricot) extracts ameliorates tnbs-induced ulcerative colitis in rats</article-title><source>Res. Pharm. Sci.</source><year>2014</year><volume>9</volume><fpage>225</fpage><pub-id pub-id-type="pmid">25657793</pub-id></element-citation></ref><ref id="B20-ijms-20-00405"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatters</surname><given-names>D.M.</given-names></name><name><surname>Peters-Libeu</surname><given-names>C.A.</given-names></name><name><surname>Weisgraber</surname><given-names>K.H.</given-names></name></person-group><article-title>Apolipoprotein E structure: Insights into function</article-title><source>Trends Biochem. Sci.</source><year>2006</year><volume>31</volume><fpage>445</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2006.06.008</pub-id><pub-id pub-id-type="pmid">16820298</pub-id></element-citation></ref><ref id="B21-ijms-20-00405"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenfeld</surname><given-names>M.E.</given-names></name><name><surname>Polinsky</surname><given-names>P.</given-names></name><name><surname>Virmani</surname><given-names>R.</given-names></name><name><surname>Kauser</surname><given-names>K.</given-names></name><name><surname>Rubanyi</surname><given-names>G.</given-names></name><name><surname>Schwartz</surname><given-names>S.M.</given-names></name></person-group><article-title>Advanced atherosclerotic lesions in the innominate artery of the apoe knockout mouse</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2000</year><volume>20</volume><fpage>2587</fpage><lpage>2592</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.20.12.2587</pub-id><pub-id pub-id-type="pmid">11116057</pub-id></element-citation></ref><ref id="B22-ijms-20-00405"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locatelli</surname><given-names>S.</given-names></name><name><surname>L&#x000fc;tjohann</surname><given-names>D.</given-names></name><name><surname>Schmidt</surname><given-names>H.H.-J.</given-names></name><name><surname>Otto</surname><given-names>C.</given-names></name><name><surname>Beisiegel</surname><given-names>U.</given-names></name><name><surname>von Bergmann</surname><given-names>K.</given-names></name></person-group><article-title>Reduction of plasma 24s-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: Evidence that simvastatin affects cholesterol metabolism in the human brain</article-title><source>Arch. Neurol.</source><year>2002</year><volume>59</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1001/archneur.59.2.213</pub-id><?supplied-pmid 11843691?><pub-id pub-id-type="pmid">11843691</pub-id></element-citation></ref><ref id="B23-ijms-20-00405"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Scandinavian Simvastatin Survival Study Group</collab></person-group><article-title>Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study (4s)</article-title><source>Lancet</source><year>1994</year><volume>344</volume><fpage>1383</fpage><lpage>1389</lpage><pub-id pub-id-type="pmid">7968073</pub-id></element-citation></ref><ref id="B24-ijms-20-00405"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libby</surname><given-names>P.</given-names></name></person-group><article-title>Atherosclerosis: Disease biology affecting the coronary vasculature</article-title><source>Am. J. Cardiol.</source><year>2006</year><volume>98</volume><fpage>S3</fpage><lpage>S9</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2006.09.020</pub-id></element-citation></ref><ref id="B25-ijms-20-00405"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raber</surname><given-names>J.</given-names></name><name><surname>Wong</surname><given-names>D.</given-names></name><name><surname>Buttini</surname><given-names>M.</given-names></name><name><surname>Orth</surname><given-names>M.</given-names></name><name><surname>Bellosta</surname><given-names>S.</given-names></name><name><surname>Pitas</surname><given-names>R.E.</given-names></name><name><surname>Mahley</surname><given-names>R.W.</given-names></name><name><surname>Mucke</surname><given-names>L.</given-names></name></person-group><article-title>Isoform-specific effects of human apolipoprotein E on brain function revealed in apoe knockout mice: Increased susceptibility of females</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1998</year><volume>95</volume><fpage>10914</fpage><lpage>10919</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.18.10914</pub-id><pub-id pub-id-type="pmid">9724804</pub-id></element-citation></ref><ref id="B26-ijms-20-00405"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>R.</given-names></name><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Aiuchi</surname><given-names>T.</given-names></name><name><surname>Sawada</surname><given-names>N.</given-names></name><name><surname>Obama</surname><given-names>T.</given-names></name><name><surname>Itabe</surname><given-names>H.</given-names></name></person-group><article-title>Temporal and spatial changes of peroxiredoxin 2 levels in aortic media at very early stages of atherosclerotic lesion formation in apoe-knockout mice</article-title><source>Free Radic. Biol. Med.</source><year>2018</year><volume>130</volume><fpage>348</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.10.458</pub-id><?supplied-pmid 30395970?><pub-id pub-id-type="pmid">30395970</pub-id></element-citation></ref><ref id="B27-ijms-20-00405"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drexler</surname><given-names>H.</given-names></name><name><surname>Hornig</surname><given-names>B.</given-names></name></person-group><article-title>Endothelial dysfunction in human disease</article-title><source>J. Mol. Cell. Cardiol.</source><year>1999</year><volume>31</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1006/jmcc.1998.0843</pub-id><pub-id pub-id-type="pmid">10072715</pub-id></element-citation></ref><ref id="B28-ijms-20-00405"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonetti</surname><given-names>P.O.</given-names></name><name><surname>Lerman</surname><given-names>L.O.</given-names></name><name><surname>Lerman</surname><given-names>A.</given-names></name></person-group><article-title>Endothelial dysfunction: A marker of atherosclerotic risk</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2003</year><volume>23</volume><fpage>168</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000051384.43104.FC</pub-id><?supplied-pmid 12588755?><pub-id pub-id-type="pmid">12588755</pub-id></element-citation></ref><ref id="B29-ijms-20-00405"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname><given-names>E.M.</given-names></name><name><surname>Rosenberg</surname><given-names>R.D.</given-names></name></person-group><article-title>Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells</article-title><source>Mol. Cell. Biol.</source><year>1988</year><volume>8</volume><fpage>5588</fpage><lpage>5592</lpage><pub-id pub-id-type="doi">10.1128/MCB.8.12.5588</pub-id><?supplied-pmid 2854203?><pub-id pub-id-type="pmid">2854203</pub-id></element-citation></ref><ref id="B30-ijms-20-00405"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgington</surname><given-names>T.S.</given-names></name><name><surname>Mackman</surname><given-names>N.</given-names></name><name><surname>Brand</surname><given-names>K.</given-names></name><name><surname>Ruf</surname><given-names>W.</given-names></name></person-group><article-title>The structural biology of expression and function of tissue factor</article-title><source>Thromb. Haemost.</source><year>1991</year><volume>66</volume><fpage>067</fpage><lpage>079</lpage><pub-id pub-id-type="doi">10.1055/s-0038-1646375</pub-id></element-citation></ref><ref id="B31-ijms-20-00405"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meisel</surname><given-names>S.R.</given-names></name><name><surname>Ouyang</surname><given-names>Y.</given-names></name><name><surname>Fishbein</surname><given-names>M.C.</given-names></name><name><surname>Edgington</surname><given-names>T.S.</given-names></name><name><surname>Ruan</surname><given-names>X.M.</given-names></name><name><surname>Cercek</surname><given-names>B.</given-names></name><name><surname>Shah</surname><given-names>P.K.</given-names></name><name><surname>Chaux</surname><given-names>A.</given-names></name></person-group><article-title>Prolonged hypercholesterolemia-induced tissue factor expression in rabbit vein grafts: A potential mechanism for graft failure</article-title><source>Coron. Artery Dis.</source><year>2010</year><volume>21</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1097/MCA.0b013e328336e9f3</pub-id><?supplied-pmid 20087175?><pub-id pub-id-type="pmid">20087175</pub-id></element-citation></ref><ref id="B32-ijms-20-00405"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maly</surname><given-names>M.A.</given-names></name><name><surname>Tomasov</surname><given-names>P.</given-names></name><name><surname>Hajek</surname><given-names>P.</given-names></name><name><surname>Blasko</surname><given-names>P.</given-names></name><name><surname>Hrachovinova</surname><given-names>I.</given-names></name><name><surname>Salaj</surname><given-names>P.</given-names></name><name><surname>Veselka</surname><given-names>J.</given-names></name></person-group><article-title>The role of tissue factor in thrombosis and hemostasis</article-title><source>Physiol. Res.</source><year>2007</year><volume>56</volume><fpage>685</fpage><lpage>695</lpage><?supplied-pmid 17087602?><pub-id pub-id-type="pmid">17087602</pub-id></element-citation></ref><ref id="B33-ijms-20-00405"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadir</surname><given-names>Y.</given-names></name><name><surname>Brenner</surname><given-names>B.</given-names></name><name><surname>Zetser</surname><given-names>A.</given-names></name><name><surname>Ilan</surname><given-names>N.</given-names></name><name><surname>Shafat</surname><given-names>I.</given-names></name><name><surname>Zcharia</surname><given-names>E.</given-names></name><name><surname>Goldshmidt</surname><given-names>O.</given-names></name><name><surname>Vlodavsky</surname><given-names>I.</given-names></name></person-group><article-title>Heparanase induces tissue factor expression in vascular endothelial and cancer cells</article-title><source>J. Thromb. Haemost.</source><year>2006</year><volume>4</volume><fpage>2443</fpage><lpage>2451</lpage><pub-id pub-id-type="doi">10.1111/j.1538-7836.2006.02212.x</pub-id><?supplied-pmid 16970801?><pub-id pub-id-type="pmid">16970801</pub-id></element-citation></ref><ref id="B34-ijms-20-00405"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerthoffer</surname><given-names>W.T.</given-names></name></person-group><article-title>Mechanisms of vascular smooth muscle cell migration</article-title><source>Circ. Res.</source><year>2007</year><volume>100</volume><fpage>607</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000258492.96097.47</pub-id><?supplied-pmid 17363707?><pub-id pub-id-type="pmid">17363707</pub-id></element-citation></ref><ref id="B35-ijms-20-00405"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.S.</given-names></name><name><surname>Li</surname><given-names>X.J.</given-names></name><name><surname>Zhao</surname><given-names>W.O.</given-names></name></person-group><article-title>Trem-1 is a positive regulator of TNF-&#x003b1; and IL-8 production in u937 foam cells</article-title><source>Bosn. J. Basic Med. Sci.</source><year>2012</year><volume>12</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.17305/bjbms.2012.2503</pub-id><?supplied-pmid 22642593?><pub-id pub-id-type="pmid">22642593</pub-id></element-citation></ref><ref id="B36-ijms-20-00405"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>QI</surname><given-names>Z.-X.</given-names></name><name><surname>Lei</surname><given-names>C.</given-names></name></person-group><article-title>Effect of chinese drugs for promoting blood circulation and eliminating blood stasis on vascular endothelial growth factor expression in rabbits with glucocorticoid-induced ischemic necrosis of femoral head</article-title><source>J. Tradit. Chin. Med.</source><year>2009</year><volume>29</volume><fpage>137</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/S0254-6272(09)60050-9</pub-id><pub-id pub-id-type="pmid">19663102</pub-id></element-citation></ref><ref id="B37-ijms-20-00405"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>A.</given-names></name><name><surname>Onoda</surname><given-names>K.</given-names></name><name><surname>Kawashima</surname><given-names>K.</given-names></name><name><surname>Nakaura</surname><given-names>S.</given-names></name><name><surname>Nagao</surname><given-names>S.</given-names></name><name><surname>Endo</surname><given-names>T.</given-names></name><name><surname>Ohno</surname><given-names>Y.</given-names></name><name><surname>Kawanishi</surname><given-names>T.</given-names></name><name><surname>Takanaka</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Toxicological studies on biological effect of herbal drug extracts on rats and mice&#x02014;Peony root, peach kernel, Japanese angelica root and cnidium rhizome</article-title><source>Yakugaku Zasshi</source><year>1983</year><volume>103</volume><fpage>937</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1248/yakushi1947.103.9_937</pub-id><pub-id pub-id-type="pmid">6674491</pub-id></element-citation></ref><ref id="B38-ijms-20-00405"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>K.J.</given-names></name><name><surname>Schmittgen</surname><given-names>T.D.</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>&#x02212;&#x00394;&#x00394;<italic>C</italic></sup><sub>T</sub> method</article-title><source>Methods</source><year>2001</year><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="B39-ijms-20-00405"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zetterqvist</surname><given-names>A.V.</given-names></name><name><surname>Berglund</surname><given-names>L.M.</given-names></name><name><surname>Blanco</surname><given-names>F.</given-names></name><name><surname>Garcia-Vaz</surname><given-names>E.</given-names></name><name><surname>Wigren</surname><given-names>M.</given-names></name><name><surname>Dun&#x000e9;r</surname><given-names>P.</given-names></name><name><surname>Andersson</surname><given-names>A.-M.D.</given-names></name><name><surname>To</surname><given-names>F.</given-names></name><name><surname>Spegel</surname><given-names>P.</given-names></name><name><surname>Nilsson</surname><given-names>J.</given-names></name></person-group><article-title>Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e65020</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0065020</pub-id><pub-id pub-id-type="pmid">23755169</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-20-00405-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Experimental design, workflow and chemicals used in this study. (<bold>A</bold>) Peach kernel oil on human umbilical vein endothelial cells (HUVEC) endothelial cells viability; (<bold>B</bold>) Peach kernel oil on reducing atherosclerosis in ApoE knockout (KO) mice; (<bold>C</bold>) GC-MS analysis of the major components of peach kernel oil. PKO stands for peach kernel oil.</p></caption><graphic xlink:href="ijms-20-00405-g001"/></fig><fig id="ijms-20-00405-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Cell viability, TF expression at mRNA and protein levels in HUVEC after treated with different concentration of peach kernel oil. No chemicals were added in the normal group. As a vehicle control, DMSO was added for evaluating the solvent effect. For the model group, TNF-&#x003b1; was added to the culture medium to stimulate TF protein expression. For the positive group, simvastatin was added to HUVEC to suppress the TF protein induction by TNF-&#x003b1; stimulation. After pretreating HUVEC with simvastatin or peach kernel oil, TNF-&#x003b1; protein was added to HUVEC culture medium to induce TF protein expression. (<bold>A</bold>) Cell viability of HUVEC after treated with different concentrations of peach kernel oil. The TF expression at mRNA (<bold>B</bold>) or protein (<bold>C</bold>) level in HUVEC after treated with different concentrations of peach kernel oil. (<bold>D</bold>&#x02013;<bold>L</bold>) The expression of TF protein in HUVEC after treated with peach kernel oil detected by immunohistochemistry (yellow color). The cell nuclei were counterstained with DAPI. PKO stands for peach kernel oil. Different labels above columns in (<bold>A</bold>&#x02013;<bold>C</bold>) indicate a significant difference tested by One-way ANOVA between different experimental groups with <italic>p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="ijms-20-00405-g002"/></fig><fig id="ijms-20-00405-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The lipid levels of TC, TG, HDL-C and LDL-C in the serum of ApoE-knockout (KO) mice. (<bold>A</bold>) Total cholesterol (TC), (<bold>B</bold>) Triglyceride (TG), (<bold>C</bold>) High-density lipoprotein cholesterol (HDL-C), and (<bold>D</bold>) Low-density lipoprotein cholesterol (LDL-C) levels in the serum were measured after feeding with high-fat diet for 8 weeks. Different labels above columns in (<bold>A</bold>&#x02013;<bold>D</bold>) indicate a significant difference tested by One-way ANOVA between different experimental groups with <italic>p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="ijms-20-00405-g003"/></fig><fig id="ijms-20-00405-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Histology and immunohistochemistry assay of the aorta of ApoE knockout (KO) mice at 400&#x000d7; magnification after treating with peach kernel oil (PKO). (<bold>A</bold>) Normal aorta in normal mice without high-fat diet feeding (normal group); (<bold>B</bold>) Aorta in normal mice fed with high-fat diet feeding for eight weeks (normal group); (<bold>C</bold>) Aorta in ApoE KO mice fed with high-fat feeding for eight weeks (model group); (<bold>D</bold>) Aorta of ApoE KO mice fed with high-fat feeding and simvastatin (positive group); (<bold>E</bold>) Aorta of ApoE KO mice fed with high-fat feeding and high dose peach kernel oil (PKO); (<bold>F</bold>) Aorta of ApoE KO mice fed with high-fat feeding and low dose PKO (<bold>G</bold>) Quantitative results from lumen area (statistics was tested by One-way ANOVA and Tukey-HSD test, <italic>p</italic> &#x0003c; 0.01). Different labels above columns in (<bold>G</bold>) indicate a significant difference tested by One-way ANOVA between different experimental groups with <italic>p</italic> &#x0003c; 0.01. Immunohistochemistry assay showing TF protein expression level in atherosclerotic plaques in (<bold>H</bold>) normal group (<bold>I</bold>) model group (<bold>J</bold>) positive group (<bold>K</bold>) high dose PKO treatment and (<bold>L</bold>) low dose PKO treatment groups.</p></caption><graphic xlink:href="ijms-20-00405-g004"/></fig><fig id="ijms-20-00405-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Schematic representation of the obtained results and the protective effects of peach kernel oil to reduce Atherosclerosis in ApoE knockout Mice. The results obtained from this study are highlighted in blue color. The result obtained from previous study [<xref rid="B18-ijms-20-00405" ref-type="bibr">18</xref>] is highlighted in black color.</p></caption><graphic xlink:href="ijms-20-00405-g005"/></fig><table-wrap id="ijms-20-00405-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-20-00405-t001_Table 1</object-id><label>Table 1</label><caption><p>The comparison of aortic atherosclerotic lesions area in mice (<inline-formula><mml:math id="mm1"><mml:mrow><mml:mover accent="true"><mml:mi>X</mml:mi><mml:mo>&#x000af;</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> &#x000b1; SD, <italic>n</italic> = 8).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Grouping</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Atherosclerosis Lesions Area (&#x003bc;m<sup>2</sup>)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cross-Sectional Area of Vascular Wall (&#x003bc;m<sup>2</sup>)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Atherosclerosis Lesions Area/Cross-Sectional Area of Vascular Wall</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Model group</td><td align="center" valign="middle" rowspan="1" colspan="1">50,176 &#x000b1; 5348 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">93,118 &#x000b1; 22,508 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.547 &#x000b1; 0.074 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Positive group</td><td align="center" valign="middle" rowspan="1" colspan="1">8298 &#x000b1; 2629 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">98,249 &#x000b1; 44,394 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.087 &#x000b1; 0.013 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">High-dose PKO group</td><td align="center" valign="middle" rowspan="1" colspan="1">9396 &#x000b1; 4028 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">98,592 &#x000b1; 15,878 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.093 &#x000b1; 0.025 <sup>b</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low-dose PKO group</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21,418 &#x000b1; 5807 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">106,322 &#x000b1; 17,706 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.199 &#x000b1; 0.021 <sup>b</sup></td></tr></tbody></table><table-wrap-foot><fn><p>PKO stands for peach kernel oil; Different labels above data indicate a significant difference tested by One-way ANOVA between different experimental groups with <italic>p</italic> &#x0003c; 0.01.</p></fn></table-wrap-foot></table-wrap></floats-group></article>